Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 6, 2006, Pages 1862-1868

  Aletti, Giovanni D ^a   Dowdy, Sean ^a   Podratz, Karl C ^a   Cliby, William A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cytoreduction; Lymphadenectomy; Node metastasis; Ovarian cancer

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STATISTICS; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33751256033     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.06.068     Document Type: Article

References (15)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics 2005. CA Cancer J Clin 55 (2005) 10-30
2. Knapp R.C., and Friedman E.A. Aortic lymph node metastases in early ovarian cancer. Am J Obstet Gynecol 119 (1974) 1013-1017
3. Chen S.S. Survival of ovarian carcinoma with or without lymph node metastasis. Gynecol Oncol 27 (1987) 368-372
4. Trimbos J.B., Vergote I., Bolis G., Vermorken J.B., Mangioni C., Madronal C., et al. EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm: impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95 (2003) 113-125
5. Mayer A.R., Chambers S.K., Graves E., Holm C., Tseng P.C., Nelson B.E., et al. Ovarian cancer staging: Does it require a gynecologic oncologist?. Gynecol Oncol 47 (1992) 223-227
6. Zanetta G., Rota S., Chiari S., Bonazzi C., Bratina G., Torri V., et al. The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. Ann Oncol 9 (1998) 1097-1101
7. Spirtos N.M., Gross G.M., Freddo J.L., and Ballon S.C. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 56 (1995) 345-352
8. Benedetti Panici P., Maggioni A., Hacker N., Landoni F., Ackermann S., Campagnutta E., et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97 (2005) 560-566
9. Cancer Committee of the International Federation of Gynecology and Obstetrics, Staging announcement: FIGO Cancer Committee. Gynecol Oncol 25 (1986) 383-385
10. Aletti G.D., Dowdy S.C., Gostout B.S., Jones M.B., Stanhope C.R., Wilson T.O., et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 107 (2006) 77-85
11. Kigawa J., Minagawa Y., Itamochi H., Kanamori Y., Ishihara H., and Terakawa N. Retroperitoneal lymphadenectomy including the para-aortic nodes in patients with stage III ovarian cancer. Am J Obstet Gynecol 17 (1994) 230-233
12. Scarabelli C., Gallo A., Zarrelli A., Visentin C., and Campagnutta E. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol 56 (1995) 328-337
13. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Monz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during platinum era: a meta-analysis. J Clin Oncol 20 (2002) 1248-1259
14. Chambers S.K. Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved. J Natl Cancer Inst 97 (2005) 548-549
15. Di Re F., and Baiocchi G. Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium. Int J Gynecol Cancer 10 (2000) 435-442